Immunotherapy for solid tumours progresses to human trials
Drug Discovery World
AUGUST 14, 2023
Research partners in the UK are progressing their orally available small molecule cancer immunotherapy drug into clinical development as a treatment for advanced solid tumours. Chief Investigator Dr Bristi Basu, University of Cambridge, and Co-Chief Investigator Dr Debashis Sarker, King’s College London, are leading the trial.
Let's personalize your content